dipalmitoylphosphatidic acid has been researched along with Cancer of Colon in 1 studies
dipalmitoylphosphatidic acid: RN given refers to parent cpd without isomeric designation
dihexadecanoyl phosphatidic acid : A phosphatidic acid in which the phosphatidyl acyl groups are both palmitoyl (hexadecanoyl).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kondo, M | 1 |
| Asai, T | 1 |
| Katanasaka, Y | 1 |
| Sadzuka, Y | 1 |
| Tsukada, H | 1 |
| Ogino, K | 1 |
| Taki, T | 1 |
| Baba, K | 1 |
| Oku, N | 1 |
1 other study available for dipalmitoylphosphatidic acid and Cancer of Colon
| Article | Year |
|---|---|
Anti-neovascular therapy by liposomal drug targeted to membrane type-1 matrix metalloproteinase.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides | 2004 |